Stockreport

Assessing Acadia Pharmaceuticals (ACAD) Valuation After Strong Q3 Results and Extended NUPLAZID Patent Protection [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF Acadia Pharmaceuticals (ACAD) is back in focus after a stronger than expected third quarter pushed analysts to lift their sales estimates, helped by NUPLAZID's patent pr [Read more]